BioCentury
ARTICLE | Financial News

Intercept raises $250M in two offerings

April 6, 2018 5:10 PM UTC

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) raised $250 million on April 5 from a pair of upsized offerings.

The liver disease company raised $150 million through the sale of 2.3 million shares at $64 in a bumped-up follow-on underwritten by Credit Suisse and Jefferies. The price is a small discount to the company's close of $64.36 on April 4, when it proposed after-hours to raise $120 million...